Extended-Release Naltrexone, Treatment For Alcohol Dependence, Improves Quality-of-life Measures

Most studies examining the impact of alcohol-dependence (AD) treatment on quality-of-life (QOL) have looked at psychosocial treatments. This study looked at the impact of pharmacotherapy on QOL, specifically, the effects of extended-release naltrexone (XR-NTX), a once-a-month injectable formulation for the treatment of AD. Results showed significant improvements in the QOL areas of mental health, social functioning, general health, and physical functioning.

More: continued here

Filed under: Alcohol / Addiction / Illegal Drugs on December 4th, 2008